Type 1 Diabetes (T1D) Clinical Trials

Find Type 1 Diabetes (T1D) Clinical Trials Near You

Circadian Mechanisms of Glycemic Control and Cardiovascular Risk in Adults With Type 1 Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. The investigators propose to conduct a mechanistic study using a sleep stability manipulation. This proposal will advance the understanding of mechanisms by which improving sleep regularity influences glycemic control and cardiovascular risk in T1D.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: f
View:

• Adults 18-50 years with a clinical diagnosis of T1D for at least one year

• Report habitual sleep irregularity ≥1 hour/week

• Desire to improve sleep, and own a smartphone (Android or iPhone)

Locations
United States
Illinois
University of Illinois Chicago
RECRUITING
Chicago
Contact Information
Primary
Pamela Martyn-Nemeth, PhD
pmartyn@uic.edu
312-996-7903
Backup
Sirimon Reutrakul, MD
sreutrak@uic.edu
312-996-6060
Time Frame
Start Date: 2025-03-13
Estimated Completion Date: 2029-08-31
Participants
Target number of participants: 100
Treatments
Other: Single arm
Sleep stability intervention
Related Therapeutic Areas
Sponsors
Leads: University of Illinois at Chicago
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)

This content was sourced from clinicaltrials.gov